Dec 22, 2022 | Teresa Miceli
There is so much information being produced and shared at the American Society of Hematology (ASH) Annual Meeting, it is challenging to digest it all and distill it down. In review of the many screen shots I took of the presentation slides, one piece of information...
Dec 21, 2022 | Jessie Daw
Dr. Sigrun Thorsteinsdottir, MD, PhD, gave a comprehensive review of smoldering myeloma directed toward practitioners. The session was very informative and so I’d like to dedicate this blog to sharing this information from a patient’s perspective, as I’ll highlight...
Dec 13, 2022 | Jessie Daw
As I mentioned in my previous blog, the uncertainties of living with smoldering multiple myeloma (SMM) can be whittled down to two “million dollar” questions: (a) “Will I progress to active disease?” and (b) “Should I consider treatment, and if so, how and when?” This...
Dec 13, 2022 | Jack Aiello
Today was the final day of ASH, but it was still full of information, and to be honest, I’m a bit brain-fried. For me, the day started with an excellent Education Spotlight session on “Underrepresented minorities in clinical trials…”. It was chaired by multiple...
